Henry Schein (NASDAQ:HSIC) Releases Q4 2024 Earnings Guidance

Henry Schein (NASDAQ:HSIC) updated its fourth quarter 2024 earnings guidance on Wednesday. The company provided EPS guidance of 1.190-1.190 for the period, compared to the consensus EPS estimate of 1.230. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.3 billion. Henry Schein also updated its FY 2024 guidance to 4.740-4.740 EPS.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Barrington Research raised their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $80.10.

Henry Schein Stock Down 0.1 %

Shares of HSIC opened at $79.77 on Thursday. The business’s 50 day simple moving average is $73.19 and its 200-day simple moving average is $71.27. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.63. The stock has a market capitalization of $9.95 billion, a price-to-earnings ratio of 32.81, a price-to-earnings-growth ratio of 2.04 and a beta of 0.89. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.32 earnings per share. As a group, equities analysts expect that Henry Schein will post 4.78 earnings per share for the current fiscal year.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.